CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value
$89.79+0.27 (+0.30%)
Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%
Cvs Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cvs Health's enterprise value was $162.06B on Nov 11, 2026, against $156.59B a year earlier. Over the last 5 years it ranged from $112.22B to $186.56B, with a median of $147.19B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $162.06B | +4.3% |
| 2025 | Dec 31, 2025 | $155.32B | +38.4% |
| 2024 | Dec 31, 2024 | $112.22B | -23.8% |
| 2023 | Dec 29, 2023 | $147.19B | -4.9% |
| 2022 | Dec 30, 2022 | $154.73B | -15.0% |
| 2021 | Dec 31, 2021 | $182.14B | +26.2% |
| 2020 | Dec 31, 2020 | $144.34B | -8.8% |
| 2019 | Dec 31, 2019 | $158.22B | +80.4% |
| 2018 | Dec 31, 2018 | $87.72B | -9.1% |
| 2017 | Dec 29, 2017 | $96.49B | +17.4% |
| 2016 | Dec 30, 2016 | $82.20B | -38.1% |
| 2015 | Dec 31, 2015 | $132.74B | +20.0% |
| 2014 | Dec 31, 2014 | $110.62B | +16.7% |
| 2013 | Dec 31, 2013 | $94.76B | +37.2% |
| 2012 | Dec 31, 2012 | $69.05B | +10.7% |
| 2011 | Dec 30, 2011 | $62.40B | +8.8% |
| 2010 | Dec 31, 2010 | $57.38B | +1.5% |
| 2009 | Dec 31, 2009 | $56.52B | – |
See a number that looks wrong?